Microbiopsy Market Outlook (2023 to 2033)

The microbiopsy market size is projected to be worth USD 157.5 million in 2023. The market is likely to surpass USD 305.7 million by 2033 at a CAGR of 6.9% during the forecast period. The creation, manufacture, and distribution of microbiopsy equipment and associated goods are the primary objectives of the microbiopsy market, a subset of the medical diagnostics and research business.

For diagnostic or research reasons, microbiopsy involves the minimally invasive sample of body tissue or cells. Microbiopsies often get smaller tissue samples, which are less intrusive and uncomfortable for patients than standard biopsies, which remove larger tissue samples.

Other Drivers Propelling the Demand for Microbiopsy include:

  • The rising need for less-invasive diagnostic techniques is one of the key factors driving the microbiopsy market. Traditional surgical biopsies can be replaced with less invasive microbiopsy procedures that cause less pain, scarring, and take less time to heal. The need for microbiopsy equipment and technology is being driven by the rising preference of patients and healthcare professionals for microbiopsy treatments when practical.
  • Effective and fast diagnostic tests are required because chronic diseases like cancer, skin problems, and autoimmune diseases are becoming more common.
  • The market for microbiopsies is being impacted by the rise of personalized medicine and targeted therapeutics. In order to collect tissue samples for genetic and molecular profiling, which helps identify particular biomarkers and therapeutic targets, microbiopsy procedures are essential.

Challenges for Companies /Manufacturers in the Microbiopsy Market:

  • Small tissue samples are collected during microbiopsies, frequently using minimally invasive methods. Getting enough tissue for precise analysis and diagnosis is the difficult part. A significant problem is ensuring an acceptable sample size while minimizing patient discomfort and tissue damage.
  • Different laboratories and healthcare facilities may use different microbiopsy protocols, which might result in variations in sample collection, processing, and analysis. Lack of standardization impedes the capacity to create trustworthy diagnostic criteria as well as the reproducibility and comparability of results. To address this issue, standard operating procedures and guidelines for microbiopsy techniques must be created.

Opportunities in the Microbiopsy Industry:

  • Personalizing medical care for each patient based on their unique traits is known as personalized medicine, and it is becoming more popular. To obtain patient-specific tissue samples for molecular profiling, genomic analysis, and the choice of targeted therapies, microbiopsy is essential.
  • Innovative microbiopsy technologies can be developed through partnerships between academic institutions, research organizations, and business stakeholders. Partnerships that concentrate on strengthening tissue preservation technologies, sample collection procedures, and analysis and diagnostic skills might open up new possibilities and spur industry expansion.

Latest Trends in the Microbiopsy Market:

  • For effective therapy to be achieved, early disease detection is essential for conditions like cancer. Microbiopsies provide a minimally intrusive way to collect tissue samples for the early diagnosis of disease, enabling prompt treatment and better patient outcomes.
  • Imaging techniques like ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), and optical coherence tomography (OCT) are frequently incorporated into microbiopsy procedures for their benefits. These imaging techniques enhance the precision of tissue sample by assisting in real-time guiding and localization of the biopsy site.
Attributes Details
Microbiopsy Market Size (2023) USD 157.5 million
Microbiopsy Market Projected Size (2033) USD 305.7 million
Value CAGR (2023 to 2033) 6.9%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

2012 to 2022 Microbiopsy Demand Outlook Compared to 2023 to 2033 Forecast

From 2012 to 2022, the global microbiopsy market experienced a CAGR of 5.1%, reaching a market size of USD 157.5 million in 2023.

A minimally invasive biopsy method called microbiopsy includes taking small tissue samples for analysis or research. Microbiopsy technique have evolved within the molecular diagnosis and research arena over the years. From 2012 to 2022, the market for microbiopsy tools and services has expanded steadily. Microbiopsy has been applied in various domain including infectious disease diagnosis like leishmaniasis or viral warts, skin oncology like basel cell carcinoma (BCC) and melanoma.

Future Forecast for Microbiopsy Industry:

Looking ahead, the global microbiopsy industry is expected to rise at a CAGR of 6.9% from 2023 to 2033. During the forecast period, the market size is expected to reach USD 305.7 million by 2033.

Chronic diseases such as cancer, dermatological conditions, and autoimmune disorders are on the rise globally. Microbiopsy plays a crucial role in the early diagnosis, monitoring, and treatment of these conditions. As the prevalence of chronic diseases continues to increase, the demand for microbiopsy techniques and devices is expected to grow.

Technological advancements have led to the development of more advanced and precise microbiopsy devices. These devices offer improved accuracy, minimal tissue damage, and reduced patient discomfort. The introduction of automated and handheld microbiopsy devices has made the procedure more accessible and efficient. Ongoing research and development in the field are expected to drive further advancements, expanding the market.

Country-Wise Insights

Microbiopsy Market to Surge in the United States Due to Rising Prevalence of Cancer.

Country The United States
Market Size (USD million) by End of Forecast Period (2033) USD 96.3 million
CAGR % 2023 to End of Forecast (2033) 6.4%

The microbiopsy industry in the United States is expected to reach a market size of USD 96.3 million by 2033, expanding at a CAGR of 6.4%. Rising prevalence of cancer, which has led to a higher demand for accurate and minimally invasive diagnostic procedure. Along with technology advancement has contributed to the growth of global market growth.

Rising Demand for Microbiopsy by Healthcare Professional to Propel the United Kingdom Market Growth

Country The United Kingdom
Market Size (USD million) by End of Forecast Period (2033) USD 15.6 million
CAGR % 2023 to End of Forecast (2033) 6.3%

The microbiopsy industry in the United Kingdom is expected to reach a market value of USD 15.6 million, expanding at a CAGR of 6.3% during the forecast period. The United Kingdom market is projected to growth of the market due to the growing demand for microbiopsy by healthcare professionals. Also, UK has robust healthcare system with a high focus on innovation which created favorable environment for the growth of the microbiopsy market.

Notable Growth Expected in China's Microbiopsy Market as Due to Government Investment in healthcare infrastructure

Country China
Market Size (USD million) by End of Forecast Period (2033) USD 18.7 million
CAGR % 2023 to End of Forecast (2033) 8.1%

The microbiopsy industry in China is anticipated to reach a market size of USD 18.7 million, moving at a CAGR of 8.1% during the forecast period. The Chinese government is investing heavily in advancing healthcare infrastructure and technology in the country. Also, private healthcare expenditure on advanced diagnostics has contributed to the growth of microbiopsy market in China.

Growing Awareness and Acceptance to Drive Market Growth in Japan

Country Japan
Market Size (USD million) by End of Forecast Period (2033) USD 15.2 million
CAGR % 2023 to End of Forecast (2033) 7.4%

The microbiopsy industry in Japan is estimated to reach a market size of USD 15.2 million by 2033, thriving at a CAGR of 7.4%. Increasing adoption of robotics and biopsy procedures is driving the growth of the market in Japan. These advanced technologies offer greater precision and accuracy, while also reducing the risk of tissue damage and infection.

Demand for Microbiopsy is Rising Due to Increasing Personalized Medicine to Fuel Market Growth in South Korea

Country South Korea
Market Size (USD million) by End of Forecast Period (2033) USD 13.5 million
CAGR % 2023 to End of Forecast (2033) 8.8%

The microbiopsy industry in South Korea is expected to reach a market size of USD 13.5 million, expanding at a CAGR of 8.8% during the forecast period. The market in South Korea is forecasted to witness growth as government has implemented various initiatives to improve the country’s healthcare system. Also, the rising demand for personalized medicine in south Korea.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Category-Wise Insights

Microbiopsy Needle to Dominate Microbiopsy Industry with 8.2% CAGR through 2033

The microbiopsy needle is expected to dominate the microbiopsy industry with a CAGR of 8.2% from 2023 to 2033. Microbiopsy needles are made specifically to collect minute tissue samples from selected body parts. These needles include either a tiny needle tip or a cutting edge that allows for regulated and precise tissue collection. For precise diagnosis, research, and treatment planning, the capacity to acquire high-quality tissue samples with little damage or contamination is crucial. The improvement of tissue sampling made possible by microbiopsy needles is what is causing the microbiopsy market to expand.

How the Skin Cancer are Driving the Microbiopsy Market?

The skin cancer segment is expected to dominate the microbiopsy industry with a CAGR of 8.2% from 2023 to 2033. One of the most prevalent cancers in the world is skin cancer, which includes melanoma and non-melanoma varieties such basal cell carcinoma and squamous cell carcinoma. A thorough and timely diagnosis is essential for efficient care and better patient outcomes. Tissue samples are typically obtained using microbiopsy procedures such skin punch biopsies or shave biopsies for histopathological analysis and conclusive diagnosis. The market for microbiopsy procedures is expanding as a result of the rising incidence of skin cancer and the increased demand for microbiopsy operations.

Which End User is Widely Adopted the Microbiopsy?

The hospital segment is expected to dominate the microbiopsy industry with a CAGR of 6.7% from 2023 to 2033. Key centers for diagnostic services, such as microbiopsy procedures, are hospitals. Hospitals offer the required equipment, knowledge, and resources to conduct microbiopsy operations when patients present with questionable skin lesions or need tissue collection for diagnostic purposes. Specialized dermatological departments, pathology labs, and qualified medical staff that perform and analyses microbiopsy results are all found in hospitals. The need for microbiopsy procedures is driven by hospitals' accessibility to complete diagnostic services, which also helps the market expand.

How Key Players Stay Competitive in the Microbiopsy Industry?

The microbiopsy sector is fiercely competitive, with many companies fighting for market dominance. To stay ahead of the competition in such a circumstance, essential players must employ smart techniques.

Key Strategies Used by the Participants

  • Product Development

To produce innovative goods that increase efficacy, dependability, and cost-effectiveness, businesses make significant investments in research and development. Product innovation enables companies to stand out from the competition while also meeting the shifting needs of their customers.

  • Strategic Alliances & Collaborations

Key industry leaders frequently develop strategic partnerships and collaborations with other companies in order to harness their strengths and increase their market reach. Companies might also gain access to new technology and markets through such agreements.

  • Expansion into Emerging Markets

The microbiopsy sector is expanding rapidly in emerging regions such as China and India. Key firms are enhancing their distribution networks and developing local manufacturing facilities to increase their presence in these areas.

  • Acquisitions and mergers

Mergers and acquisitions are frequently used by key players in the microbiopsy business to consolidate their market position, extend their product range, and gain access to new markets.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Key Players in the Microbiopsy Industry

  • Trajan Scientific Australia Pty Ltd.
  • Vigeo
  • Zamar Biopsy
  • Medax
  • AprioMed
  • Hologic
  • Mammotome
  • M.D.L.
  • Histo
  • Changzhou Mingle Medical Equipment Co., Ltd.
  • Surtex Instruments Limited
  • STERIS
  • MICRO-TECH EUROPE
  • Boston Scientific Corporation

Key Developments in the Microbiopsy Market:

  • In April 2022, Together with scientists from The University of Queensland (UQ), Trajan Scientific and Medical (Trajan, ASX:TRJ) created a portable skin microbiopsy equipment that collects tissue samples with a diameter of less than 0.5 mm. The instrument is made to gather biopsies for disorders of the skin, including skin cancer.
  • In January 2021, A market leader in women's health, Hologic, Inc. (Nasdaq: HOLX), has announced that it has reached an agreement to purchase privately held, commercial-stage startup Biotheranostics, Inc., which offers molecular diagnostic tests for breast and metastatic cancers.

Segmentation Analysis of the Microbiopsy Market

By Product:

  • Microbiopsy Needle
  • Microbiopsy Forceps
  • Microbiopsy Devices

By Indication:

  • Skin cancer
  • Actinic keratosis
  • Dermatitis
  • Others

By End User:

  • Hospitals
  • Specialty Clinics
  • Cancer Institutes

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

Frequently Asked Questions

What is the Growth Potential of The Microbiopsy Market?

The market is forecast to record a CAGR of 6.9% through 2033.

What is the Projected Size of The Market by 2033?

The market is valued to attain USD 305.7 million by 2033.

How Big is the Market?

The market is estimated to secure a valuation of USD 157.5 million in 2023.

What is the Market CAGR of China?

The China market is to flourish at an 8.1% CAGR.

Which Product Is Widely Utilized in The Market?

With a CAGR of 8.2%, the microbiopsy needle category takes precedence in the market.

What is the Market CAGR of the United States?

The market in the United States is to develop at a CAGR of 6.4%.

Table of Content
  • 1. Executive Summary
  • 2. Market Overview
  • 3. Key Market Trends
  • 4. Value Added Insights
  • 5. Market Background
  • 6. Global Market Volume (in Units) Analysis 2012 to 2022 and Forecast, 2023 to 2033
  • 7. Global Market - Pricing Analysis
  • 8. Global Market Demand (in Value or Size in USD Million) Analysis 2012 to 2022 and Forecast, 2023 to 2033
  • 9. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Product
    • 9.1. Needle
    • 9.2. Forceps
    • 9.3. Devices
  • 10. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Indication
    • 10.1. Skin cancer
    • 10.2. Actinic keratosis
    • 10.3. Dermatitis
    • 10.4. Others
  • 11. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By End User
    • 11.1. Hospitals
    • 11.2. Specialty Clinics
    • 11.3. Cancer Institutes
  • 12. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, by Region
    • 12.1. North America
    • 12.2. Latin America
    • 12.3. Europe
    • 12.4. South Asia
    • 12.5. East Asia
    • 12.6. Oceania
    • 12.7. Middle East and Africa (MEA)
  • 13. North America Market Analysis 2012 to 2022 and Forecast 2023 to 2033
  • 14. Latin America Market Analysis 2012 to 2022 and Forecast 2023 to 2033
  • 15. Europe Market Analysis 2012 to 2022 and Forecast 2023 to 2033
  • 16. South Asia Market Analysis 2012 to 2022 and Forecast 2023 to 2033
  • 17. East Asia Market Analysis 2012 to 2022 and Forecast 2023 to 2033
  • 18. Oceania Market Analysis 2012 to 2022 and Forecast 2023 to 2033
  • 19. Middle East and Africa Market Analysis 2012 to 2022 and Forecast 2023 to 2033
  • 20. Market Structure Analysis
  • 21. Competition Analysis
    • 21.1. Trajan Scientific Australia Pty Ltd.
    • 21.2. Vigeo
    • 21.3. Zamar Biopsy
    • 21.4. Medax
    • 21.5. AprioMed
    • 21.6. Hologic
    • 21.7. Mammotome
    • 21.8. M.D.L.
    • 21.9. Histo
    • 21.10. Changzhou Mingle Medical Equipment Co., Ltd.
    • 21.11. Surtex Instruments Limited
    • 21.12. STERIS
    • 21.13. MICRO-TECH EUROPE
    • 21.14. Boston Scientific Corporation
  • 22. Assumptions and Acronyms Used
  • 23. Research Methodology

Explore Healthcare Insights

View Reports
Future Market Insights

Microbiopsy Market

Schedule a Call